Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Accumulated OCI history
Currency unavailable · from the balance sheet
No Accumulated OCI data reported for this period type.
Accumulated OCI vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $3.86M USD | -10.8% | +2.7% | 0.5% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | +100.0% | — | 0.0% | |
| Mar 2026 | -$26.29K USD | -2619.0% | -40.7% | 0.0% | |
| Jun 2026 | -$3.83M USD | -2321.5% | — | 0.2% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -1166.1% | -19.0% | 0.0% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.